Showing 1,528 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Activism & civil society

Community demand for temporary halt to Gilead DISCOVER study

Editor's pick
HIV Prevention Justice Alliance
17 November 2016
Activism & civil society

Why Are HIV Groups Charging Gilead With Bad Behavior in New PrEP Trial?

Editor's pick
The Body
17 November 2016
PrEP

Statement on DISCOVER Study of F/TAF for PrEP

Editor's pick
Gilead Sciences
16 November 2016
Pharmaceutical industry

‘Hard’ Brexit would delay access to new drugs, warns report

Editor's pick
Pharma Times
9 November 2016
Access to healthcare

These researchers think they have a solution to the global crisis in drug prices

Editor's pick
Washington Post
8 November 2016
Pharmaceutical industry

Gilead sales of Hepatitis C drugs slump

Editor's pick
MarketWatch
2 November 2016
Pharmaceutical industry

Get ready for more drug ads: Facebook is making a bid for pharma dollars

Editor's pick
STAT
1 November 2016
Pharmaceutical industry

GSK discontinues development of maturation inhibitor BMS-986173

Editor's pick
HIV i-Base
31 October 2016
Finance & funding

Generic HIV drugs will be a good thing right?

Editor's pick
Project Inform
27 October 2016
Pharmaceutical industry

Treat pharma as a utility, and 10 other ways states can lower drug prices

Editor's pick
STAT
19 October 2016
Child developmental issues

No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

News
10 October 2016
Pharmaceutical industry

European regulator amends some Gilead hep C patent claims

Editor's pick
STAT
6 October 2016
Pharmaceutical industry

CHMP Recommends for Approval Generic Version of Truvada

Editor's pick
EATG
20 September 2016
Hepatitis C treatment

Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Editor's pick
Bloomberg
19 September 2016
Pharmaceutical industry

Janssen Submits Marketing Authorisation Application for Darunavir-Based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency

Editor's pick
Janssen-Cilag press release
13 September 2016
Hepatitis B

ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

Editor's pick
ContraVir press release
12 September 2016
Pharmaceutical industry

Drug firm boss who raised price of HIV medicine trolls Hillary Clinton after collapse at 9/11 memorial service

Editor's pick
Mirror.co.uk
12 September 2016
TB treatment

WHO launches Target Regimen Profiles for TB treatment

Editor's pick
World Health Organization
8 September 2016
Access to healthcare

Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

Editor's pick
MSF
7 September 2016
Access to healthcare

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Editor's pick
STAT
7 September 2016
Access to healthcare

Ukraine's medicine bill slashed by 25% after UK firm brought in to handle procurement

Editor's pick
The Guardian
1 September 2016
Pharmaceutical industry

University of Minnesota sues Gilead Sciences over hepatitis drugs

Editor's pick
Minneapolis Star Tribune
31 August 2016
Pharmaceutical industry

Glaxo Bets It Can Shake Up HIV Treatment

Editor's pick
Wall Street Journal
30 August 2016
Pharmaceutical industry

Gilead Ignored HIV Groups Before Failed Bid To Have PrEP Subsidised In Australia

Editor's pick
BuzzFeed
25 August 2016